共 180 条
[1]
Nordmann P(2019)Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria Clin Infect Dis 69 S521-S528
[2]
Poirel L(2006)Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Antimicrob Agents Chemother 50 1633-1641
[3]
Quale J(2009) clinical isolates Antimicrob Agents Chemother 53 4783-4788
[4]
Bratu S(2003)Molecular epidemiology and mechanisms of carbapenem resistance in Microbiol Mol Biol Rev 67 593-656
[5]
Gupta J(2017)Molecular basis of bacterial outer membrane permeability revisited Clin Microbiol Rev 30 1-22
[6]
Landman D(2022)Carbapenem-resistant Clin Infect Dis 75 187-212
[7]
Rodríguez-Martínez JM(2022) and Enterobacteriaceae in South and Southeast Asia Antimicrob Agents Chemother 66 e0003922-680
[8]
Poirel L(2021)Infectious Diseases Society of America 2022 Guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa) Antimicrob Agents Chemother 65 e0087721-66
[9]
Nordmann P(2022)Impact of acquired broad-spectrum β-lactamases on susceptibility to cefiderocol and newly developed β-lactam/β-lactamase inhibitor combinations in Eur J Clin Microbiol Infect Dis 41 677-S650
[10]
Nikaido H(2023) and Int J Antimicrob Agents 62 106917-e00120